Pikagi
MindMed Profile Banner
MindMed Profile
MindMed

@mindmedco

24,037
Followers
256
Following
193
Media
588
Statuses

MindMed is a clinical stage biopharma company developing psychedelics and other novel treatments for brain health disorders. $MNMD $MMED

https://t.co/m9tHycSpr2
Joined September 2019
Don't wanna be here? Send us removal request.
Pinned Tweet
@mindmedco
MindMed
@mindmedco
1 month
Join us on August 13, 2024, at 8:00 AM ET for our quarterly earnings conference call where we will discuss our Q2 2024 financial results and provide business updates. Links to press release and registration are in the first comments.
Tweet media one
2
8
26
Last Seen Profiles
Elma Ammirati

@elma_ammira

Selen Cansu Aksoy

@selencansu5

Tasneem

@toxqv

Sarah Stuffins

@SarahStuffins59

𝒜𐙚

@oouussak

CLAUDIO SOUZA

@CLAUDIOJPSOUZA

巨乳岳母

@dxhdxf2

Ren

@bbyofflora

Mohamed Youssef

@MYousefOfficial

Damar

@guagwgue

(☆IRL CARTMAN☆)

@ericcartman_30

Nucleus

@withnucleus

🌸中洲スカウト🌸クラブ・キャバクラ・ラウンジ『福岡水商売特化』パン君🐒

@Naron__ttt5

Jason Kan

@0xAtticKnight

Nado H.

@astronaut_nado

ナガノ ヒロキ

@hiroki_quiz

ananda (taylor's version)

@lovelyonl

Fernando Hernández

@Fake_bandicoot

MUSEBiz

@MuseBizUK

SmashHit - EU Project (GA 871477)

@SmashhitP

Barbara Blaha

@barbarablaha

h a l o s

@warmhalo

Sri Venkatesh

@BrindavanExp

INFO BOKEP LOKAL TANTE SEMOK

@bokeplokalmalam

Lord$hed🇬🇭

@isaac_lordshed

Pierre Labarbe

@PierreLabarbe

Adriana Messina

@Adrianamessina9

منيوك ممحون ابي مبادل

@AsSa66986762

PrincessRiRI / RhiannonRyder 🦄

@RyderRhiannon

American Brain Tumor Association

@theABTA

@ksapa.org

@KsapaOrg

NYT Obituaries

@NYTObits

Martin Hallett 🇮🇱

@MartinHallett3

Bohim

@Bohim00013503

Penyuka Binor dan Stw

@Sukabinorstw11

Perry County Vikings Athletics

@PCVikingSports

@mindmedco
MindMed
@mindmedco
3 years
BREAKING: @NASDAQ listed - MNMD. 🧠
Tweet media one
35
169
751
@mindmedco
MindMed
@mindmedco
3 years
Officially part of the @NASDAQ family - $MNMD is open for business. 🧠
Tweet media one
31
93
672
@mindmedco
MindMed
@mindmedco
3 years
MindMed and the entire field of psychedelic medicine are ready to take off! #removethestigma #mentalhealthawareness
Tweet media one
9
80
415
@mindmedco
MindMed
@mindmedco
3 years
We are excited to start our human clinical trial with DMT - the active ingredient in Ayahuasca.
19
77
371
@mindmedco
MindMed
@mindmedco
3 years
Massive news for the world of psychedelic medicine and its potential benefits.
Tweet card media
NYU is launching a center for psychedelic medicine

NYU’s Langone Health joins the research renaissance.

www.freethink.com
12
62
303
@mindmedco
MindMed
@mindmedco
3 years
A new study finds that patients who take a single psychedelic dose of psilocybin, 25mg, in conjunction with therapy report rapid and significant reduction in depression symptoms.
8
82
294
@mindmedco
MindMed
@mindmedco
3 years
It's time to profoundly change how we address mental health. 🧠
Tweet card media
Can LSD cure our pandemic anxiety? MindMed is spending big to find out

MindMed is one of several companies experimenting with psychedelics to treat anxiety and addiction.

fortune.com
6
79
289
@mindmedco
MindMed
@mindmedco
3 years
“Psychedelic therapeutics have moved from the fringes of medicine to the mainstream.” 🍄
6
64
274
@mindmedco
MindMed
@mindmedco
3 years
For the first time in history, Mental Health had its own agenda item at this year’s World Health Assembly.
Tweet card media
Mental health makes history at the 74th World Health Assembly - United for Global Mental Health

For the first time in history, Mental Health had its own agenda item at this year’s World Health Assembly - the annual meeting of health ministers and policy makers from around the world. Discussions...

unitedgmh.org
6
56
268
@mindmedco
MindMed
@mindmedco
3 years
The FDA has cleared MindMed’s IND application for MM-120, our proprietary, pharmacologically optimized form of LSD. Our Phase 2b dose-optimization trial of MM-120 for the treatment of Generalized Anxiety Disorder is expected to start in early 2022.
Tweet card media
FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder - MindMed

– FDA clearance leads to first commercial IND for LSD, enabling initiation of Phase 2b dose-optimization trial of MM-120 in early 2022 –  NEW YORK, January 25, 2022 — Mind Medicine (MindMed) Inc....

mindmed.co
7
62
277
@mindmedco
MindMed
@mindmedco
3 years
"A 2020 study from Johns Hopkins University showed that two doses of psilocybin produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of the study participants achieving full remission."
9
74
271
@mindmedco
MindMed
@mindmedco
3 years
Research has shown that the hallucinogenic compound psilocybin in mushrooms may have long-lasting benefits in reducing anxiety and depression.
Tweet card media
Mushrooms for Anxiety: The Potential Power of Psilocybin

Psilocybin mushrooms are at the center of some exciting research around new mental health treatments, but how do they actually affect anxiety symptoms?

www.healthline.com
6
53
238
@mindmedco
MindMed
@mindmedco
3 years
Happy Birthday to the mind behind MindMed, our CEO and Co-Founder, @thejrrahn ! 🚀
Tweet media one
14
15
238
@mindmedco
MindMed
@mindmedco
3 years
Research has shown that psychedelics can help treat historically difficult-to-treat conditions by essentially “reshaping” the way “parts of the brain talk to each other.” Companies like MindMed are helping pave the way.
Tweet card media
Psychedelic trips could soon be part of therapy — here’s what those sessions will look like

In as soon as two years, tripping on mind-altering drugs like MDMA and psilocybin could become a regular part of therapy to treat conditions from depression to post-traumatic stress disorder.

www.cnbc.com
9
64
213
@mindmedco
MindMed
@mindmedco
3 years
"'Magic Mushrooms' can cause an increase in the number of neuronal connections and thus position itself as one of the better treatments for major depression." Learn more:
6
44
206
@mindmedco
MindMed
@mindmedco
3 years
MindMed is pleased to announce an expansion of its pipeline with the launch of a program to develop R(-)-MDMA for the treatment of social anxiety and functioning in diagnoses that include Autism Spectrum Disorder (ASD).
MindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), (DE: MMQ); the "Company"), a leading biotech company developing psychedelic-inspired...

www.prnewswire.com
7
40
207
@mindmedco
MindMed
@mindmedco
3 years
"Alcohol accounts for about 3 million deaths worldwide annually, and there are only four approved drugs to treat alcohol use disorder." Find out how German researchers are using psilocybin to cut alcohol cravings and boost key brain functions.
Tweet card media
Psychedelic psilocybin cuts cravings and boosts key brain functions in rat models of alcohol use...

Alcohol accounts for about 3 million deaths worldwide annually, and there are only four approved drugs to treat alcohol use disorder. | Researchers at the University of Heidelberg treated rat models...

www.fiercebiotech.com
6
56
199
@mindmedco
MindMed
@mindmedco
6 months
Today, we announced the FDA has granted breakthrough therapy designation for MM120 in GAD. We also announced positive 12-week durability data from our Phase 2b study of MM120 in GAD and are hosting a call at 8AM ET to discuss details. Read more: $MNMD
Tweet media one
0
48
198
@mindmedco
MindMed
@mindmedco
3 years
“DMT-assisted psychotherapy could actually be one of the best treatments ever.”
Tweet card media
Is DMT the best new treatment for depression?

Psychedelic therapy could bring the ancient healing powers of drugs like DMT into mental health clinics.

www.freethink.com
7
46
192
@mindmedco
MindMed
@mindmedco
3 years
MindMed Leverages psychoactive brew ayahuasca which is known for having a fast-onset antidepressant effect. Learn more about how serotonergic psychedelics are giving promising results in the quest for alternative treatments for depression and anxiety here:
5
31
179
@mindmedco
MindMed
@mindmedco
3 years
This is why we do it. Such an incredible story from @CBSNews !
Tweet card media
New hope in treating PTSD with psychedelic drugs

Some service members and others suffering from Post-Traumatic Stress Disorder (PTSD) have had little relief from traditional anti-depressants used in conjunction with psychotherapy. Now, a recent...

www.cbsnews.com
6
37
184
@mindmedco
MindMed
@mindmedco
3 years
Psychedelic trips could soon be part of therapy — here’s what those sessions will look like.
Tweet card media
Psychedelic trips could soon be part of therapy — here’s what those sessions will look like

In as soon as two years, tripping on mind-altering drugs like MDMA and psilocybin could become a regular part of therapy to treat conditions from depression to post-traumatic stress disorder.

www.cnbc.com
3
36
182
@mindmedco
MindMed
@mindmedco
4 years
The entire #mindmed team is excited to welcome Robert Barrow as Chief Development Officer. Mr. Barrow was responsible for launching the Phase 2 clinical program for psilocybin in the treatment of Major Depressive Disorder and for obtaining BTD for the program at @US_FDA
8
25
177
@mindmedco
MindMed
@mindmedco
4 years
Everyone at #mindmed is extremely pleased to announce the close of our acquisition of @healthmodeHQ ! @healthmodeHQ measurements will be used to improve efficiency & efficacy of clinical development and clinical care. More details here: @thejrrahn
Tweet card media
MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF, DE: MMQ) ("MindMed"), a leading psychedelic medicine biotech company, is pleased to...

www.prnewswire.com
7
34
173
@mindmedco
MindMed
@mindmedco
3 years
Researchers say “psychedelic-assisted psychotherapy” could be more effective at treating the symptoms of “PTSD, depression, anxiety, addictions, and social disconnection”.
6
33
174
@mindmedco
MindMed
@mindmedco
4 years
We're proud to be the first #psychedelic company to go public last year. It's just the beginning, @thejrrahn said it best, "We are still in the early innings here". @kevinolearytv
Tweet card media
More Psychedelic Companies Are Going Public

The number of psychedelic companies going public is expected to increase in 2021.

money.usnews.com
8
38
172
@mindmedco
MindMed
@mindmedco
3 years
Psilocybin, studied as an anti-depressive treatment, may affect how we perceive music. Learn more about the new academic study here:
Tweet media one
5
27
172
@mindmedco
MindMed
@mindmedco
3 years
The need for psychedelic medicine is now.
5
36
172
@mindmedco
MindMed
@mindmedco
3 years
"MindMed has one of the most diverse pipelines in psychedelics..." 🍄
Tweet card media
Why This MindMed Analyst Is Bullish: 'One Of The Most Diverse Pipelines In Psychedelics'

Mind Medicine (MindMed) Inc (NASDAQ: MNMD) shares traded higher by 3.3% on Monday after one analyst initiated bullish coverage of the psychedelics stock. The Analyst: Maxim analyst Jason McCarthy...

markets.businessinsider.com
15
36
172
@mindmedco
MindMed
@mindmedco
4 years
“Our company mission is to use psychedelic medicines to combat mental health issues.” - @thejrrahn . Checkout more on our collaboration with NYU in @Forbes ! @amanda_siebert #psychedelics #biotech @nyulangone
7
42
171
@mindmedco
MindMed
@mindmedco
3 years
Almost 1 in 5 people struggle with anxiety. What if psychedelics could potentially provide relief of symptoms to millions?
Tweet card media
Anxiety stats in the U.S.

About 31% of adults will experience anxiety at some point

www.singlecare.com
6
34
168
@mindmedco
MindMed
@mindmedco
3 years
The American mental health system is being re-engineered around psychedelics, and clinical psychedelics could begin receiving FDA approval as early as 2023. Learn more about the future of mental health and how MindMed is spearheading the change here.
Tweet media one
5
38
166
@mindmedco
MindMed
@mindmedco
3 years
Our friend @DeepakChopra says he wants to bring awareness to psychedelics as a potential source of mind-body healing. #RemoveTheStigma
Deepak Chopra says he wants to bring awareness to psychedelics as a potential source of mind-body...

Self-care leader Deepak Chopra explains why he's partnering with MindMed, a clinical-stage psychedelic medicine biotech company.

www.cnbc.com
4
36
161
@mindmedco
MindMed
@mindmedco
3 years
MindMed's Project Angie is part of ongoing studies into how psychedelics could help treat physical pain. Learn more about the latest research here:
Tweet card media
Can Psychedelic Drugs Treat Physical Pain?

LSD and psilocybin increasingly show promise as mental health treatments. Now universities and companies are exploring their use in pain management

www.scientificamerican.com
9
32
165
@mindmedco
MindMed
@mindmedco
4 years
Today at 2:45pm ET, our CEO and co-founder @JamonRahn will be speaking with @AmandaLang with @BNNBloomberg . Be sure to tune in!
Tweet media one
12
25
164
@mindmedco
MindMed
@mindmedco
3 years
LSD has the potential to be the key to alleviating the mental health crisis. 🗝 Learn more:
Tweet card media
LSD Could Be the Key to Alleviating the Mental Health Crisis—if Government Allows It

During the last decade, a number of biopharmaceutical start-ups have been working on developing psychedelic-inspired medicines through clinical trials. Given the success of early research into LSD,...

fee.org
7
42
163
@mindmedco
MindMed
@mindmedco
3 years
The future is psychedelics, and science may be starting to agree.
Tweet card media
Psychedelic Science Holds Promise for Mainstream Medicine

UNLV neuroscientists Dustin and Rochelle Hines join rising number of researchers studying possible medical benefits of psychedelics; their work on brain activity recently published by Nature:...

www.unlv.edu
5
34
166
@mindmedco
MindMed
@mindmedco
3 years
The U.S. Government recently awarded Johns Hopkins a grant to research how psychedelic therapy can impact tobacco addiction. Learn more about the grant here:
Tweet card media
Johns Hopkins receives first federal grant for psychedelic treatment research in 50 years

The nearly $4 million NIH grant will fund a multisite study of the effects of "magic mushrooms" and talk therapy on quitting smoking

hub.jhu.edu
1
23
158
@mindmedco
MindMed
@mindmedco
3 years
Listen up - mental health month continues with an interview with @thejrrahn on how psychedelics can potentially treat mental health disorders.
2
36
156
@mindmedco
MindMed
@mindmedco
4 years
The Lancet Commission report on mental health said, "Mental disorders will cost the global economy $16 trillion by 2030" Mental health is not getting better. @mindmedco is working diligently to explore new approaches to the growing mental health crisis. #psychedelic #biotech
3
29
164
@mindmedco
MindMed
@mindmedco
3 years
May is Mental Health Awareness Month! Here at MindMed, we help showcase the potential benefits that psychedelic drugs can have on one's mental health. 🍄
Tweet media one
4
36
158
@mindmedco
MindMed
@mindmedco
4 years
"NYU Langone Health and the NYU Grossman School of Medicine are ideal partners for MindMed as we continue to evaluate and research future psychedelic assisted therapies and medicines for substance abuse disorders and other mental illnesses" - @thejrrahn @hanfrish #psychedelics
@nypost
New York Post
@nypost
4 years
NYU launching $10M Center for Psychedelic Medicine in Manhattan
Tweet media one
18
33
95
5
34
161
@mindmedco
MindMed
@mindmedco
3 years
UW-Madison School of Pharmacy professor Paul Hutson states that "Psychedelic research on campus has shown that MDMA in combination with psychotherapy can reduce symptoms of PTSD by as much as 300 percent in patients." Learn more about the program here:
Tweet card media
UW-Madison Launches Center To Study Psychedelic Drugs For Use In Mental Health Treatment

Researchers at the University of Wisconsin-Madison studying the use of psychedelic drugs to treat PTSD, substance abuse and depression are coordinating efforts through a new Transdisciplinary Center...

www.wpr.org
4
31
157
@mindmedco
MindMed
@mindmedco
3 years
Researchers are working to integrate psychedelic drug and music therapy using technology that would allow a therapist to become an “emotional deejay.”
Tweet card media
Christine Sismondo: Researchers work to integrate psychedelic drug and music therapies using...

Combining the two predates even the 1960s and is an ancient practice in many cultures.

www.thestar.com
8
19
148
@mindmedco
MindMed
@mindmedco
4 years
The time has come... #mindmed is launching its #merch program with net proceeds going directly to your choice of non-profit organization. These will initially include @MAPS and @nyulangone Psychedelic Research Program! The latest swag can be found here:
26
30
150
@mindmedco
MindMed
@mindmedco
3 years
It’s time to destigmatize mental illness and psychedelics. 🧠 @DeepakChopra chatted with @chelseahandler about MindMed and the potential benefits that psychedelic drugs can have.
@chelseahandler
Chelsea Handler
@chelseahandler
3 years
The first time I took acid would have been at The Limelight in NYC around the age of 17. What was your first psychedelic experience? Listen to my talk with @DeepakChopra and more on the latest episode of Dear Chelsea.
65
11
231
3
33
147
@mindmedco
MindMed
@mindmedco
3 years
We are excited to launch a new study evaluating the effects of daytime and evening administration of repeated low doses of LSD. 💤 Learn more:
MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD; NEO: MMED; DE: MMQ; the "Company"), a leading biotech company developing psychedelic-inspired...

www.prnewswire.com
12
28
145
@mindmedco
MindMed
@mindmedco
2 years
MindMed today announced first patient dosing in its Phase 2b dose-optimization trial of MM-120, a pharmaceutically optimized form of LSD. Learn more about the trial here:
Tweet card media
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

www.prnewswire.com
18
29
153
@mindmedco
MindMed
@mindmedco
3 years
Psychedelics are offering a potential treatment to our veterans in need.
Tweet card media
Could Group Therapy Get a Boost From Psychedelics?

Researchers are beginning to investigate whether “group dosing” could help patients connect more deeply.

www.wsj.com
0
27
145
@mindmedco
MindMed
@mindmedco
4 years
The team at #MindMedco is ecstatic to get started! #biotech
@Benzinga
Benzinga
@Benzinga
4 years
MindMed Begins First-Ever Clinical Trial On MDMA, LSD Combinations $MMEDF
0
17
60
5
21
146
@mindmedco
MindMed
@mindmedco
3 years
Honored to be the first NEO-listed issuer to be added to the MSCI Canada Index!
Tweet media one
5
24
144
@mindmedco
MindMed
@mindmedco
4 years
If you haven't had a chance to checkout MindMed's revamped website, head over to ! The most up to date news on clinical trials and all other @mindmedco initiatives within #psychedelics can be found here. #biotech
Tweet media one
12
21
144
@mindmedco
MindMed
@mindmedco
4 years
@mindmedco acquired @healthmodeHQ ! The move will help build a full stack digital mental health platform for psychedelic medicines. We welcome former @pfizer Digital Medicine Executive @dankarlin M.D. M.A. and former @Google AI/ML industry veteran @bradfordcross . More below:
3
24
144
@mindmedco
MindMed
@mindmedco
3 years
So proud to be part of the @US_FDA 's digital health collaborative community!
@FDADeviceInfo
FDA Medical Devices
@FDADeviceInfo
3 years
The @US_FDA is participating in the #DigitalHealth collaborative community, an effort to develop best practices and streamline the field’s approaches to measuring health using digital technologies. Find out more:
0
8
24
4
26
145
@mindmedco
MindMed
@mindmedco
3 years
MindMed welcomes our new CEO @RobertBBarrow . After serving as interim CEO and CDO of MindMed, we are excited to have Rob bring his strategic expertise and deep industry insight to this role.
Tweet media one
9
15
143
@mindmedco
MindMed
@mindmedco
4 years
2020 was a pivotal year for #psychedelics and #mindmed . We are more determined than ever before to work toward our goal of creating a new toolset for #mentalhealth & #addiction @businessinsider @thejrrahn
@BusinessInsider
Business Insider
@BusinessInsider
4 years
What to know about the major public psychedelics companies, including a guide to their business models and when they expect to sell medications
4
10
39
5
28
142
@mindmedco
MindMed
@mindmedco
3 years
MindMed is excited to announce that it has joined the Critical Path Institute's ("C-Path's") Patient-Reported Outcome (PRO) Consortium to assist in the development of new approaches to advance medical innovation and regulatory science. Learn more here:
MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired...

www.prnewswire.com
5
13
137
@mindmedco
MindMed
@mindmedco
3 years
CEO, @thejrrahn talks the move to @Nasdaq . 🧠🚀
Tweet card media
Mind Medicine CEO JR Rahn and Kevin O'Leary on MNMD move to the...

Mind Medicine CEO JR Rahn and Shark Tank investor Kevin O'Leary stop by the show to fill us in on the company's first day trading on the Nasdaq. In the move...

www.youtube.com
2
27
141
@mindmedco
MindMed
@mindmedco
3 years
One of the world's most iconic investors, @kevinolearytv , stresses the importance of portfolio diversification. Diversification in psychedelics.
Exclusive: Kevin O'Leary Talks Crypto, Psychedelics And The Importance Of Investment Diversification

Investor and "Shark Tank" star Kevin O'Leary recently sat down with Benzinga to discuss a range of subjects, including his recent pivot to psychedelics, his new investment in crypto, as well as his...

www.benzinga.com
3
23
142
@mindmedco
MindMed
@mindmedco
3 years
Researchers are calling the new wave of psychedelic medicines a ‘paradigm shifter’ for psychiatry. Learn more here:
Tweet card media
‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health

In what’s been described as a ‘paradigm shifter’ for psychiatry, Australian clinical trials are exploring the therapeutic benefits of illegal substances

www.theguardian.com
1
29
138
@mindmedco
MindMed
@mindmedco
3 years
“I believe Psychedelics are going to be a multi-billion dollar pharmacy space.” Kevin O’Leary joins Midas Letter and talks about the future of MindMed. Check out their interview here ⬇️
3
21
141
@mindmedco
MindMed
@mindmedco
4 years
We have officially received a positive response on protocol design for a Phase 2a clinical trial evaluating microdoses of LSD in the treatment of adult ADHD from the Swiss and Dutch health authorities.
MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase...

/PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, has received a positive response on its...

www.prnewswire.com
9
19
135
@mindmedco
MindMed
@mindmedco
3 years
Pandemic stress has left the mental health of frontline health care workers in a state of crisis. The University of Washington will treat 30 medical professionals diagnosed with depression with a dose of synthetic psilocybin along with psychotherapy.
9
20
138
@mindmedco
MindMed
@mindmedco
3 years
Despite the fact that around 450 million people globally suffer from mental illnesses, access to mental healthcare is still a challenge and it's crucial to provide treatment. MindMed is helping by using psychedelic medicines and therapies. Learn more:
0
22
132
@mindmedco
MindMed
@mindmedco
2 years
Today we celebrated (almost) one year as a Nasdaq-listed company. Thank you to @Nasdaq for hosting us and thank you to all of our teammates, both near and far, who made this day possible. There's so much more to come!
Tweet media one
9
10
134
@mindmedco
MindMed
@mindmedco
4 years
Investors are looking into new potential therapies like #psychedelics to transform how we treat mental health. Checkout @Forbes reporting on the subject here: "Why Investors Are Bullish On Psychedelics"
3
32
130
@mindmedco
MindMed
@mindmedco
3 years
While there’s no doubt that ketamine reduces depression by inhibiting the NMDA receptor. Some scientists including neuropharmacologist, Todd Gould, think there’s more to the story. Find the full article below.
Tweet card media
Are Psychedelics the Next Big Treatment for Depression?

For the millions of people suffering from depression, ketamine could be a brilliant fix—if the trippy side-effects were gone.

www.thedailybeast.com
6
24
128
@mindmedco
MindMed
@mindmedco
3 years
A new ETF has joined the NYSE, which marks another step forward for the psychedelic medicine industry. Learn more about PSIL here:
Tweet media one
6
19
130
@mindmedco
MindMed
@mindmedco
4 years
There’s a vast body of research that points to the therapeutic benefits psychedelic treatment can provide for people with mental health issues. We are committed to studying these options in a safe, rigorous, and federally-compliant way.
3
28
127
@mindmedco
MindMed
@mindmedco
3 years
Excited to be partnering with Datavant! We will be utilizing Datavant's linking technology across various stages of the drug lifecycle including discovery, clinical development, and commercialization. Learn more here:
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company

/PRNewswire/ -- MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, and Datavant, Inc....

www.prnewswire.com
1
19
127
@mindmedco
MindMed
@mindmedco
3 years
As psychedelic therapy is becoming more mainstream - it's important to know just how "magic mushrooms" can potentially be used to treat mental health diagnoses, such as depression and post-traumatic stress disorder (PTSD).
Tweet card media
Psychedelic therapy: For depression, PTSD, addiction, and more

Psychedelic therapy is the use of plants and compounds that can induce hallucinations to treat mental health diagnoses, such as depression and PTSD. Learn more.

www.medicalnewstoday.com
7
24
126
@mindmedco
MindMed
@mindmedco
3 years
Psychedelics are changing society's approach to mental health. To better understand how psychedelics will transform psychiatry, read more through the link below.
Tweet card media
Will the magic of psychedelics transform psychiatry?

Psychedelics have come a long way since their hallucinogenic hippy heyday. Research shows that they could alleviate PTSD, depression and addiction. So will we all soon be treated with magic mushrooms...

www.theguardian.com
1
24
120
@mindmedco
MindMed
@mindmedco
4 years
"Can LSD cure our pandemic anxiety? MindMed is spending big to find out" Checkout the full article by the talented @jeffjohnroberts in @FortuneMagazine below: @thejrrahn #Biotechnology #psychedelics
Tweet card media
Can LSD cure our pandemic anxiety? MindMed is spending big to find out

MindMed is one of several companies experimenting with psychedelics to treat anxiety and addiction.

fortune.com
3
35
119
@mindmedco
MindMed
@mindmedco
3 years
Michael Pollan's new book discusses how "psychedelics could contribute to alleviating mental health problems". A must read for all! 📚
Tweet card media
‘Psychedelics could contribute to alleviating mental health problems’: Michael Pollan’s controver...

Michael Pollan has done maybe more than any other writer to change the way we eat, the way we think about food and the way we think full-stop.Time magazine...

www.independent.ie
4
19
122
@mindmedco
MindMed
@mindmedco
3 years
Through its recent collaboration with Forian, MindMed has a first to market opportunity to develop an individualized, personalized treatment for anxiety-related disorders. Read more here:
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For...

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired...

www.prnewswire.com
3
17
113
@mindmedco
MindMed
@mindmedco
3 years
Reaching new frontiers at @MassGeneralNews with the creation of their new center to study psychedelic mental health.
Tweet card media
MGH Establishes New Center To Study Psychedelic Mental Health Treatment

"We're pretty convinced that there's a story there that these substances do change the brain or allow the brain to change in a way that can be helpful for those who suffer psychiatric disorders,"...

www.wbur.org
1
16
118
@mindmedco
MindMed
@mindmedco
4 years
“We’re not OK,” @JamonRahn told @nathanheller . 11% of Americans seriously considered suicide in June. It’s time for innovative and novel solutions to society’s mental health crises. MindMed’s work with @NYULangone aims to create them. More in @NewYorker :
Tweet card media
Turn On, Tune In, Get Well

New York is getting its first psychedelic-medicine center, with the help of a startup called MindMed, which develops hallucinogens to treat mental illness and addiction, and is funding an institute...

www.newyorker.com
12
31
114
@mindmedco
MindMed
@mindmedco
4 years
We agree @tferriss ! We're excited to have the opportunity to build the infrastructure for a potential new paradigm of treatments using #psychedelic medicines. @thejrrahn @nyulangone #Biotechnology #psychedelics
@tferriss
Tim Ferriss
@tferriss
4 years
This is a big deal. Huge congratulations to the entire team at @nyulangone and all of the supporters who helped make this possible!
8
21
230
1
15
116
@mindmedco
MindMed
@mindmedco
4 years
Our co-founder and CEO @JamonRahn spoke at the @Benzinga Small Cap Conference about the story behind MindMed, the impact of COVID-19 on our mental health, and how we achieved unicorn status for the first time earlier this week. Watch here:
Tweet card media
MindMed Psychedelic Inspired medicines $MMEDF | Benzinga Small Cap...

Mind Medicine (MindMed) Inc MindMed is a neuro-pharmaceutical company that discovers, develops, and deploys psychedelic inspired medicines to improve health ...

www.youtube.com
5
14
117
@mindmedco
MindMed
@mindmedco
4 years
. @kevinolearytv likes to invest in “novel solutions to big problems.” Addressing our society’s mental health and substance abuse crises might be the biggest problem yet. It’s an honor to have him on this mission with us.
Tweet card media
Kevin O'Leary of 'Shark Tank': Why I'm betting big on psychedelics, and how investors should be...

With Oregon becoming the first state to legalize psychedelics, the "Shark Tank" investor shares three things to look out for.

www.businessinsider.com
3
21
115
@mindmedco
MindMed
@mindmedco
3 years
"At least 8.9 million American adults have both mental illness and substance use disorder. Yet millions go untreated because of the structural separation between mental health and addiction services." #WorldMentalHealthDay
5
15
113
@mindmedco
MindMed
@mindmedco
3 years
The psychedelic industry is constantly growing and now including the development of psychedelic-inspired therapies to address addiction and mental illnesses. Learn more:
Tweet media one
2
19
112
@mindmedco
MindMed
@mindmedco
3 years
As the COVID-19 pandemic raged, so did the country’s other epidemic. Drug overdose deaths rose nearly 30 percent in 2020 to a record 93,000. MindMed is hard at work to battle this ongoing epidemic. Learn more:
Tweet card media
‘It’s Huge, It’s Historic, It’s Unheard-of’: Drug Overdose Deaths Spike (Published 2021)

As Covid raged, so did the other epidemic in the U.S.: In 2020, the country experienced the largest recorded single-year increase in overdose deaths.

www.nytimes.com
4
23
111
@mindmedco
MindMed
@mindmedco
6 months
Our Phase 2b trial of MM120 in GAD patients met its key secondary endpoint, demonstrating clinically & statistically significant durability of activity observed through week 12 after a single dose with no additional therapeutic intervention. Read more:
Tweet media one
0
25
110
@mindmedco
MindMed
@mindmedco
3 years
As Warren Buffet once said, “only when the tide goes out do you discover who's been swimming naked." MindMed, however, is serious about becoming a long-term leader in the biotech sector.
Tweet card media
The Most Compelling Drug Pipeline in Psychedelics? | MindMed (MNMD)

Since we last spoke with Mind Medicine (MindMed) Inc (NASDAQ:MNMD, NEO:MMED), the company has completed a transition of its Chief Executive Officer. The new ...

www.youtube.com
5
13
113
@mindmedco
MindMed
@mindmedco
3 years
With the rise in opioid-related deaths, prescribers are put in a difficult position when treating patients struggling with mental health. Psychedelics can be a safe and effective new solution.
Tweet card media
Reducing Opioids for Pain Patients Linked to Higher Rates of Overdose and Mental Health Crisis

UC Davis Health study warns of risks associated with opioid dose tapering. Opioid therapy is complex. In recent years, a rise in opioid-related deaths and changing prescribing guidelines and regula...

scitechdaily.com
3
19
113
@mindmedco
MindMed
@mindmedco
3 years
Promising studies and destigmatization are making psychedelics an increasingly viable treatment for mental illness. Learn more about the history and future of psychedelic therapy here:
Tweet card media
The rise of psychedelic medicine — Quartz

Psychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.

classic.qz.com
3
14
112
@mindmedco
MindMed
@mindmedco
3 years
CEO @RobertBBarrow is talking about MindMed worldwide. Most recently, he was at the Jefferies London Healthcare Conference! 🌍 🚀
Tweet media one
4
10
109
@mindmedco
MindMed
@mindmedco
3 years
Fantastic interview by our CEO, Robert Barrow. Thanks for having us @YahooFinance ! 🎉
@YahooFinance
Yahoo Finance
@YahooFinance
3 years
“How we’re going to differentiate is to continue to take a rigorous scientific and pharmaceutical development approach… bringing in top people [and] novel assets,” @mindmedco 's Robert Barrow says. “We’re not selling psilocybin. Our early assets are LSD and an ibogaine analogue.”
3
10
56
8
17
110
@mindmedco
MindMed
@mindmedco
3 years
Our co-founder and CEO, @thejrrahn sat down with @Benzinga to talk all things MindMed. Check it out! 🚀
0
26
106
@mindmedco
MindMed
@mindmedco
3 years
MindMed CEO Robert Barrow has a new mission to "build the best drug pipeline in psychedelics." Check out the full Midas Letter interview here:
4
13
105
@mindmedco
MindMed
@mindmedco
3 years
"Social anxiety disorder is a prevalent and often debilitating psychiatric disorder that can assume a chronic course even when treated." Learn more about MDMA-assisted therapy here:
Tweet media one
2
11
104
@mindmedco
MindMed
@mindmedco
5 months
Tune in to @MadMoneyOnCNBC this evening at 6pm ET, where our CEO, Robert Barrow, sits down with host, @JimCramer to discuss the business of MindMed. $MNMD @CNBC
Tweet media one
10
19
95
@mindmedco
MindMed
@mindmedco
4 years
Transforming healthcare through #psychedelics !
2
18
104
@mindmedco
MindMed
@mindmedco
4 years
Checkout the latest from @thejrrahn being interviewed about @mindmedco in @fDiIntelligence @FT . If 2020 was the year of the “psychedelic unicorn”, Mr Rahn predicts that 2021 will be the “graduation year”. Full article here: @sethofarrell
7
21
103
@mindmedco
MindMed
@mindmedco
3 years
Our next "Mind behind MindMed" is Chief Medical Officer Daniel R. Karlin, MD MA. He led clinical, informatics, and regulatory strategy and served as Global Clinical Lead for psychiatry clinical compounds for Pfizer. He now leads MindMed's work in digital medicine.
Tweet media one
2
9
104
@mindmedco
MindMed
@mindmedco
3 years
"This is about how to allocate capital to mental health" -CEO, @thejrrahn via @YahooFinance @AlexisTVNews
Tweet card media
MindMed CEO on going public: ‘This is about how to allocate capital to mental health’

JR Rahn, CEO & Co Founder of MindMed, joins Yahoo Finance’s Sibile Marcellus and Alexis Christoforous to discuss MindMed going public on the Nasdaq and outlook on the psychedelics industry.

ca.finance.yahoo.com
1
26
105
@mindmedco
MindMed
@mindmedco
4 years
Today, we launched Albert, a new digital medicine division aimed at developing a more robust understanding of the value of a treatment and long-term impact on patient outcomes.
MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines

/PRNewswire/ -- MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company, is establishing a digital medicine division known...

www.prnewswire.com
1
13
100
@mindmedco
MindMed
@mindmedco
2 years
We can't wait for Dr. Liechti to share his latest work, which we believe validates MindMed's clinical approach to developing LSD for anxiety disorders. This data builds on a scientific legacy dating back to the 1940s!
Tweet media one
7
21
100
@mindmedco
MindMed
@mindmedco
4 years
The #addiction pandemic has been exacerbated by Covid-19. Creating a new paradigm of #addiction treatments is @mindmedco 's mission. "Deaths attributed to synthetic opioids, mainly fentanyl, increased 38 percent nationwide, but 98 percent in 10 western states." More below:
3
18
101